Andreas is a serial entrepreneur, who has built deep tech startups in Asia, Europe, and the US. After selling his last company Proteona to Singleron Biotechnologies, he has been heading their global business development, applying single cell technologies to precision medicine. Andreas is involved in multiple startups as board member, mentor, and shareholder. Andreas holds a PhD in immunology from Berkeley and was an early entrepreneur in the Singapore-MIT Alliance of Research and Technology (SMART)